{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:16:01Z","timestamp":1792185361516,"version":"4.4.0"},"reference-count":133,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>During the last years, studies investigating the intriguing association between immunodeficiency and autoimmunity led to the discovery of new monogenic disorders, the improvement in the knowledge of the pathogenesis of autoimmunity, and the introduction of targeted treatments. Autoimmunity is observed with particular frequency in patients with primary antibody deficiencies, such as common variable immunodeficiency (CVID) and selective IgA deficiency, but combined immunodeficiency disorders (CIDs) and disorders of innate immunity have also been associated with autoimmunity. Among CIDs, the highest incidence of autoimmunity is described in patients with autoimmune polyendocrine syndrome 1, LRBA, and CTLA-4 deficiency, and in patients with STAT-related disorders. The pathogenesis of autoimmunity in patients with immunodeficiency is far to be fully elucidated. However, altered germ center reactions, impaired central and peripheral lymphocyte negative selection, uncontrolled lymphocyte proliferation, ineffective cytoskeletal function, innate immune defects, and defective clearance of the infectious agents play an important role. In this paper, we review the main immunodeficiencies associated with autoimmunity, focusing on the pathogenic mechanisms responsible for autoimmunity in each condition and on the therapeutic strategies. Moreover, we provide a diagnostic algorithm for the diagnosis of PIDs in patients with autoimmunity.<\/jats:p>","DOI":"10.3390\/jcm10204729","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T13:35:47Z","timestamp":1634304947000},"page":"4729","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Autoimmunity in Primary Immunodeficiency Disorders: An Updated Review on Pathogenic and Clinical Implications"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4160-3727","authenticated-orcid":false,"given":"Giorgio","family":"Costagliola","sequence":"first","affiliation":[{"name":"Section of Clinical and Laboratory Immunology, Division of Pediatrics, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Cappelli","sequence":"additional","affiliation":[{"name":"Section of Clinical and Laboratory Immunology, Division of Pediatrics, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Consolini","sequence":"additional","affiliation":[{"name":"Section of Clinical and Laboratory Immunology, Division of Pediatrics, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/MOP.0000000000000833","article-title":"Autoimmunity as a continuum in primary immunodeficiency","volume":"31","author":"Walter","year":"2019","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaut.2019.01.011","article-title":"Primary immunodeficiency and autoimmunity: A comprehensive review","volume":"99","author":"Rojas","year":"2019","journal-title":"J. Autoimmun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10875-016-0294-1","article-title":"Autoimmunity and Primary Immunodeficiency Disorders","volume":"36","author":"Allenspach","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/hematology.2019000051","article-title":"Primary immunodeficiencies: Novel genes and unusual presentations","volume":"2019","author":"Notarangelo","year":"2019","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10875-017-0465-8","article-title":"The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies","volume":"38","author":"Bousfiha","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","article-title":"The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity","volume":"7","author":"Seidel","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: Division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13023-018-0941-0","article-title":"The burden of common variable immunodeficiency disorders: A retrospective analysis of the European Society for Immunodeficiency (ESID) registry data","volume":"13","author":"Odnoletkova","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2249.2011.04388.x","article-title":"Autoimmunity in primary immune deficiency: Taking lessons from our patients","volume":"164","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jaci.2012.05.046","article-title":"Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts","volume":"130","author":"Chapel","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.semarthrit.2018.02.013","article-title":"Phenotypic characterization of patients with rheumatologic manifestations of common variable immunodeficiency","volume":"48","author":"Gutierrez","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11882-016-0597-6","article-title":"Autoimmune and Lymphoproliferative Complications of Common Variable Immunodeficiency","volume":"16","author":"Maglione","year":"2016","journal-title":"Curr. Allergy Asthma. Rep."},{"key":"ref_15","first-page":"323","article-title":"Autoimmune phenotype in patients with common variable immunodeficiency","volume":"23","author":"Abolhassani","year":"2013","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.clim.2015.06.013","article-title":"Regulatory B cells in CVID patients fail to suppress multifunctional IFN-\u03b3+ TNF-\u03b1+ CD4+ T cells differentiation","volume":"160","author":"Vlkova","year":"2015","journal-title":"Clin. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.18176\/jiaci.0069","article-title":"T-Cell Abnormalities in Common Variable Immunodeficiency","volume":"26","author":"Azizi","year":"2016","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fimmu.2012.00210","article-title":"Pathogenesis of autoimmunity in common variable immunodeficiency","volume":"3","author":"Warnatz","year":"2012","journal-title":"Front Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.clim.2009.03.519","article-title":"Reduced frequency of CD4(+)CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with Common Variable Immunodeficiency: A link to autoimmunity?","volume":"132","author":"Genre","year":"2009","journal-title":"Clin. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/0394632015617064","article-title":"CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-\u03b3) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency","volume":"29","author":"Kutukculer","year":"2016","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T Follicular Helper Cell Biology: A Decade of Discovery and Diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3389\/fimmu.2018.00636","article-title":"Evaluating the Genetics of Common Variable Immunodeficiency: Monogenetic Model and Beyond","volume":"9","author":"Piquer","year":"2018","journal-title":"Front Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1182\/blood-2008-02-141937","article-title":"Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes","volume":"113","author":"Salzer","year":"2009","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.3389\/fimmu.2019.02753","article-title":"Current Understanding and Recent Developments in Common Variable Immunodeficiency Associated Autoimmunity","volume":"10","author":"Gereige","year":"2019","journal-title":"Front Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jmedgenet-2015-103690","article-title":"Genes associated with common variable immunodeficiency: One diagnosis to rule them all?","volume":"53","author":"Bogaert","year":"2016","journal-title":"J. Med. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10875-015-0177-x","article-title":"PLAID: A Syndrome of Complex Patterns of Disease and Unique Phenotypes","volume":"35","author":"Milner","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/sji.12499","article-title":"Selective IgA Deficiency: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management","volume":"85","author":"Yazdani","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clim.2003.12.005","article-title":"IgA deficiency: Clinical correlates and responses to pneumococcal vaccine","volume":"111","author":"Edwards","year":"2004","journal-title":"Clin. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1007\/s10875-007-9163-2","article-title":"Autoimmunity in IgA deficiency: Revisiting the role of IgA as a silent housekeeper","volume":"28","author":"Jacob","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1159\/000323903","article-title":"Analysis of switched memory B cells in patients with IgA deficiency","volume":"156","author":"Aghamohammadi","year":"2011","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10875-012-9702-3","article-title":"Selective IgA deficiency: Clinical and laboratory features of 118 children in Turkey","volume":"32","author":"Aytekin","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11882-013-0350-3","article-title":"Autoimmunity in immunodeficiency","volume":"13","author":"Todoric","year":"2013","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-065X.1999.tb01398.x","article-title":"The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases","volume":"167","author":"Price","year":"1999","journal-title":"Immunol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/1744666X.2017.1384312","article-title":"Autoimmunity in a cohort of 471 patients with primary antibody deficiencies","volume":"13","author":"Azizi","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10875-012-9655-6","article-title":"B-lymphocyte subpopulations in patients with selective IgA deficiency","volume":"32","author":"Nechvatalova","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/gene.2008.89","article-title":"The shared CTLA4-ICOS risk locus in celiac disease, IgA deficiency and common variable immunodeficiency","volume":"10","author":"Haimila","year":"2009","journal-title":"Genes Immun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12016-019-08756-7","article-title":"The Epidemiology and Clinical Manifestations of Autoimmunity in Selective IgA Deficiency","volume":"58","author":"Odineal","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2141.2010.08077.x","article-title":"Update on the hyper immunoglobulin M syndromes","volume":"149","author":"Davies","year":"2010","journal-title":"Br. J. Haematol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2249.2000.01142.x","article-title":"X-linked immunodeficiency with hyper-IgM (XHIM)","volume":"120","author":"Notarangelo","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1007\/s10875-008-9171-x","article-title":"Autoimmunity in hyper-IgM syndrome","volume":"28","author":"Jesus","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0092-8674(00)00079-9","article-title":"Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2)","volume":"102","author":"Revy","year":"2000","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/ni974","article-title":"Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination","volume":"4","author":"Imai","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"12614","DOI":"10.1073\/pnas.221456898","article-title":"Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM","volume":"98","author":"Ferrari","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11882-015-0553-x","article-title":"Autoimmunity and Immune Dysregulation in Primary Immune Deficiency Disorders","volume":"15","author":"Lehman","year":"2015","journal-title":"Curr. Allergy Asthma. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","article-title":"The X-linked hyper-IgM syndrome: Clinical and immunologic features of 79 patients","volume":"82","author":"Winkelstein","year":"2003","journal-title":"Medicine"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(97)70123-9","article-title":"Clinical spectrum of X-linked hyper-IgM syndrome","volume":"131","author":"Levy","year":"1997","journal-title":"J. Pediatr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2003.10.007","article-title":"Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency","volume":"110","author":"Quartier","year":"2004","journal-title":"Clin. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.4049\/jimmunol.162.9.5601","article-title":"Defective self-reactive antibody repertoire of serum IgM in patients with hyper-IgM syndrome","volume":"162","author":"Resnick","year":"1999","journal-title":"J. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.0105-2896.2005.00229.x","article-title":"Hyper immunoglobulin M syndrome due to CD40 deficiency: Clinical, molecular, and immunological features","volume":"203","author":"Lougaris","year":"2005","journal-title":"Immunol. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/pde.12685","article-title":"Consensus Communication on Early Peanut Introduction and Prevention of Peanut Allergy in High-Risk Infants","volume":"33","author":"Fleischer","year":"2016","journal-title":"Pediatr. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clim.2017.07.008","article-title":"X-Linked Agammaglobulinaemia: Outcomes in the modern era","volume":"183","author":"Shillitoe","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11882-010-0127-x","article-title":"The relationship of x-linked primary immune deficiencies and autoimmunity","volume":"10","author":"Pessach","year":"2010","journal-title":"Curr. Allergy Asthma. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","article-title":"X-linked agammaglobulinemia: Report on a United States registry of 201 patients","volume":"85","author":"Winkelstein","year":"2006","journal-title":"Medicine"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11882-004-0082-5","article-title":"X-linked immunodeficiencies","volume":"4","author":"Ochs","year":"2004","journal-title":"Curr. Allergy Asthma. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clim.2005.11.002","article-title":"The health status and quality of life of adults with X-linked agammaglobulinemia","volume":"118","author":"Howard","year":"2006","journal-title":"Clin. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.autrev.2005.10.002","article-title":"Inflammatory and autoimmune complications of common variable immune deficiency","volume":"5","author":"Knight","year":"2006","journal-title":"Autoimmun. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"11189","DOI":"10.1074\/jbc.M708516200","article-title":"Bruton\u2019s tyrosine kinase separately regulates NFkappaB p65RelA activation and cytokine interleukin (IL)-10\/IL-12 production in TLR9-stimulated B Cells","volume":"283","author":"Lee","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1084\/jem.20082392","article-title":"Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity","volume":"206","author":"Kubo","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2141.2011.08880.x","article-title":"Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: A retrospective multicentre study on 33 patients","volume":"155","author":"Gobert","year":"2011","journal-title":"Br. J. Haematol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaut.2005.04.006","article-title":"Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID)","volume":"25","author":"Wang","year":"2005","journal-title":"J. Autoimmun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/nyas.12849","article-title":"Severe combined immunodeficiency\u2014An update","volume":"1356","author":"Cirillo","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Costagliola, G., and Consolini, R. (2021). Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge. Clin. Exp. Immunol., Online ahead of print.","DOI":"10.1111\/cei.13620"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2332\/allergolint.55.115","article-title":"Omenn syndrome--review of several phenotypes of Omenn syndrome and RAG1\/RAG2 mutations in Japan","volume":"55","author":"Kato","year":"2006","journal-title":"Allergol. Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s004310100816","article-title":"Reviewing Omenn syndrome","volume":"160","author":"Aleman","year":"2001","journal-title":"Eur. J. Pediatr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fped.2016.00107","article-title":"Unbalanced Immune System: Immunodeficiencies and Autoimmunity","volume":"4","author":"Giardino","year":"2016","journal-title":"Front. Pediatr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fped.2019.00295","article-title":"Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives","volume":"7","author":"Castagnoli","year":"2019","journal-title":"Front. Pediatr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/imr.12713","article-title":"RAG gene defects at the verge of immunodeficiency and immune dysregulation","volume":"287","author":"Villa","year":"2019","journal-title":"Immunol. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nri.2016.28","article-title":"Human RAG mutations: Biochemistry and clinical implications","volume":"16","author":"Notarangelo","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-018-0083-6","article-title":"Central CD4(+) T cell tolerance: Deletion versus regulatory T cell differentiation","volume":"19","author":"Klein","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMra1713301","article-title":"Autoimmune Polyendocrine Syndromes","volume":"378","author":"Husebye","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.autrev.2017.11.012","article-title":"The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1)","volume":"17","author":"Guo","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2796.2009.02090.x","article-title":"Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I","volume":"265","author":"Husebye","year":"2009","journal-title":"J. Intern. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"15071","DOI":"10.1038\/nrdp.2015.71","article-title":"22q11.2 deletion syndrome","volume":"1","author":"Sullivan","year":"2015","journal-title":"Nat. Rev. Dis. Primers."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00018-011-0842-z","article-title":"Immunological aspects of 22q11.2 deletion syndrome","volume":"69","author":"Gennery","year":"2012","journal-title":"Cell Mol. Life Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2007.01949.x","article-title":"Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome","volume":"66","author":"Spickett","year":"2007","journal-title":"Scand. J. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/pai.12420","article-title":"Autoimmunity and regulatory T cells in 22q11.2 deletion syndrome patients","volume":"26","author":"Puliafito","year":"2015","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3389\/fimmu.2019.00447","article-title":"Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development","volume":"10","author":"Marcovecchio","year":"2019","journal-title":"Front Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/ajmg.a.38319","article-title":"The immune deficiency of chromosome 22q11.2 deletion syndrome","volume":"173","author":"Morsheimer","year":"2017","journal-title":"Am. J. Med Genet. Part A"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/cei.13429","article-title":"Vitamin D status and the immune assessment in 22q11.2 deletion syndrome","volume":"200","author":"Legitimo","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e3182060469","article-title":"Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome)","volume":"90","author":"Sullivan","year":"2011","journal-title":"Medicine"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jaci.2018.10.026","article-title":"Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency","volume":"142","author":"Cepika","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3389\/fimmu.2018.02411","article-title":"Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome","volume":"9","author":"Gambineri","year":"2018","journal-title":"Front Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12997","article-title":"Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations","volume":"190","author":"Verma","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fped.2019.00353","article-title":"Inborn Errors of Immunity With Immune Dysregulation: From Bench to Bedside","volume":"7","author":"Delmonte","year":"2019","journal-title":"Front Pediatr."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2017.07.014","article-title":"Lessons from CTLA-4 deficiency and checkpoint inhibition","volume":"49","author":"Lo","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2015.09.025","article-title":"The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency","volume":"137","author":"August","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jaip.2019.04.011","article-title":"Clinical, Immunologic, and Molecular Spectrum of Patients with LPS-Responsive Beige-Like Anchor Protein Deficiency: A Systematic Review","volume":"7","author":"Habibi","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10875-015-0224-7","article-title":"Spectrum of Phenotypes Associated with Mutations in LRBA","volume":"36","author":"Alkhairy","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.jaip.2019.06.011","article-title":"Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency","volume":"7","author":"Kiykim","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1189\/jlb.5RI0516-237RR","article-title":"STAT mutations as program switchers: Turning primary immunodeficiencies into autoimmune diseases","volume":"101","author":"Lorenzini","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s10875-020-00847-x","article-title":"Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy","volume":"40","author":"Okada","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","article-title":"Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review","volume":"7","author":"Fabre","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10875-015-0187-8","article-title":"The Ying and Yang of STAT3 in Human Disease","volume":"35","author":"Vogel","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ghir.2015.12.006","article-title":"STAT5B deficiency: Impacts on human growth and immunity","volume":"28","author":"Hwa","year":"2016","journal-title":"Growth Horm. IGF Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.clinthera.2017.01.004","article-title":"Tocilizumab Promotes Regulatory T-cell Alleviation in STAT3 Gain-of-function-associated Multi-organ Autoimmune Syndrome","volume":"39","author":"Khoury","year":"2017","journal-title":"Clin. Ther."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/ni.3753","article-title":"BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency","volume":"18","author":"Afzali","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Tessarin, G., Rossi, S., Baronio, M., Gazzurelli, L., Colpani, M., Benvenuto, A., Zunica, F., Cardinale, F., Martire, B., and Brescia, L. (2020). Activated Phosphoinositide 3-Kinase Delta Syndrome 1, Clinical and Immunological Data from an Italian Cohort of Patients. J. Clin. Med., 9.","DOI":"10.3390\/jcm9103335"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: A large patient cohort study","volume":"139","author":"Coulter","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jaci.2019.03.017","article-title":"PI3K pathway defects leading to immunodeficiency and immune dysregulation","volume":"143","author":"Uzel","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nri.2016.93","article-title":"PI3K\u03b4 and primary immunodeficiencies","volume":"16","author":"Lucas","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Dimitrova, D., Nademi, Z., Maccari, M.E., Ehl, S., Uzel, G., Tomoda, T., Okano, T., Imai, K., Carpenter, B., and Ip, W. (2021). International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome. J. Allergy Clin. Immunol., in press.","DOI":"10.1016\/j.bbmt.2019.12.079"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10875-016-0323-0","article-title":"Protein Kinase C \u03b4: A Gatekeeper of Immune Homeostasis","volume":"36","author":"Salzer","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.yjmcc.2011.07.013","article-title":"PKC-delta and PKC-epsilon: Foes of the same family or strangers?","volume":"51","author":"Duquesnes","year":"2011","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/BJ20040704","article-title":"Distinctive activation mechanisms and functions for protein kinase Cdelta","volume":"384","author":"Steinberg","year":"2004","journal-title":"Biochem. J."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood-2012-12-469544","article-title":"Loss-of-function of the protein kinase C \u03b4 (PKC\u03b4) causes a B-cell lymphoproliferative syndrome in humans","volume":"121","author":"Kuehn","year":"2013","journal-title":"Blood"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood-2014-11-567917","article-title":"JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): Common genetic etiology yet clinically distinct entities","volume":"125","author":"Calvo","year":"2015","journal-title":"Blood"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/eji.201646715","article-title":"Wiskott-Aldrich syndrome protein: Emerging mechanisms in immunity","volume":"47","author":"Rivers","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/nyas.12049","article-title":"Wiskott-Aldrich syndrome: A comprehensive review","volume":"1285","author":"Massaad","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3389\/fped.2019.00451","article-title":"Wiskott-Aldrich Syndrome (WAS) and Dedicator of Cytokinesis 8-(DOCK8) Deficiency","volume":"7","author":"Albert","year":"2019","journal-title":"Front Pediatr."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clim.2017.06.003","article-title":"DOCK8 deficiency: Insights into pathophysiology, clinical features and management","volume":"181","author":"Biggs","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.molimm.2019.08.002","article-title":"Complement deficiencies and dysregulation: Pathophysiological consequences, modern analysis, and clinical management","volume":"114","author":"Kirschfink","year":"2019","journal-title":"Mol. Immunol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/BOR.0000000000000633","article-title":"Complement, infection, and autoimmunity","volume":"31","author":"Conigliaro","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cca.2016.12.017","article-title":"Complement in autoimmune diseases","volume":"465","author":"Vignesh","year":"2017","journal-title":"Clin. Chim. Acta."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1093\/jpids\/piy014","article-title":"Noninfectious Manifestations and Complications of Chronic Granulomatous Disease","volume":"7","author":"Henrickson","year":"2018","journal-title":"J. Pediatric Infect. Dis. Soc."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12016-020-08800-x","article-title":"Chronic Granulomatous Disease: A Comprehensive Review","volume":"61","author":"Yu","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/sji.12506","article-title":"Approach to the Management of Autoimmunity in Primary Immunodeficiency","volume":"85","author":"Azizi","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaip.2016.08.004","article-title":"Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies","volume":"4","author":"Walter","year":"2016","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/hematology.2020000173","article-title":"How to evaluate for immunodeficiency in patients with autoimmune cytopenias: Laboratory evaluation for the diagnosis of inborn errors of immunity associated with immune dysregulation","volume":"2020","author":"Abraham","year":"2020","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fped.2017.00179","article-title":"The Centenary of Immune Thrombocytopenia-Part 2: Revising Diagnostic and Therapeutic Approach","volume":"5","author":"Consolini","year":"2017","journal-title":"Front Pediatr."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","article-title":"Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies","volume":"140","author":"Fischer","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clim.2017.12.009","article-title":"Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations","volume":"188","author":"Besnard","year":"2018","journal-title":"Clin. Immunol."},{"key":"ref_124","first-page":"9","article-title":"Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes","volume":"134","author":"Hadjadj","year":"2019","journal-title":"J. Am. Soc. Hematol."},{"key":"ref_125","first-page":"81","article-title":"Practical Approach to Children Presenting with Eosinophila and Hypereosinophilia","volume":"16","author":"Costagliola","year":"2020","journal-title":"Curr. Pediatr. Rev."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"593289","DOI":"10.3389\/fimmu.2020.593289","article-title":"Chronic Mucocutaneous Candidiasis in Early Life: Insights Into Immune Mechanisms and Novel Targeted Therapies","volume":"11","author":"Shamriz","year":"2020","journal-title":"Front Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1136\/annrheumdis-2014-205287","article-title":"The complement system in systemic lupus erythematosus: An update","volume":"73","author":"Leffler","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaut.2010.10.002","article-title":"Autoimmunity in common variable immunodeficiency: Correlation with lymphocyte phenotype in the French DEFI study","volume":"36","author":"Boileau","year":"2011","journal-title":"J. Autoimmun."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.clim.2008.02.013","article-title":"Memory B cells in common variable immunodeficiency: Clinical associations and sex differences","volume":"128","author":"Radigan","year":"2008","journal-title":"Clin. Immunol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1586\/eci.09.43","article-title":"Role of B cells in common variable immune deficiency","volume":"5","author":"Ahn","year":"2009","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s10875-009-9351-3","article-title":"Frequency of Treg cells is reduced in CVID patients with autoimmunity and splenomegaly and is associated with expanded CD21lo B lymphocytes","volume":"30","author":"Arumugakani","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0394632015600231","article-title":"Increased serum IgM, immunodeficiency, and autoimmunity: A clinical series","volume":"28","author":"Rosado","year":"2015","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.jaip.2019.03.014","article-title":"Immunophenotype Anomalies Predict the Development of Autoimmune Cytopenia in 22q11.2 Deletion Syndrome","volume":"7","author":"Montin","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/20\/4729\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:15:15Z","timestamp":1760166915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/20\/4729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":133,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["jcm10204729"],"URL":"https:\/\/doi.org\/10.3390\/jcm10204729","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]}}}